Table 2.
Analyses of interactions of differentially expressed miRNAs and mRNAs, considering T2D* and GDM* patients
| mRNA | microRNA | # DIANAmT | # miRanda | # miRDB | # miRWalk | # RNAhybrid | # Targetscan |
|---|---|---|---|---|---|---|---|
|
MMP1(⬇) |
miR-342-3p(⬆) |
1 |
1 |
0 |
1 |
1 |
1 |
|
RASGEF1B(⬇) |
miR-342-3p(⬆) |
1 |
1 |
0 |
1 |
1 |
1 |
|
SLC6A8(⬇) |
miR-342-3p(⬆) |
1 |
1 |
1 |
1 |
1 |
1 |
|
EIF1AY(⬆) |
miR-30b(⬆) |
1 |
1 |
0 |
1 |
1 |
1 |
|
IL1A(⬇) |
miR-30b(⬆) |
1 |
1 |
0 |
0 |
0 |
0 |
|
ZFY(⬆) |
miR-30b(⬆) |
1 |
0 |
0 |
0 |
0 |
0 |
|
ZFY(⬆) |
miR-144(⬆) |
1 |
1 |
0 |
1 |
1 |
1 |
|
EGR3(⬇) |
miR-140-3p(⬆) |
1 |
1 |
0 |
1 |
1 |
1 |
|
LPAL2(⬆) |
miR-140-3p(⬆) |
0 |
0 |
0 |
1 |
1 |
1 |
|
RASGEF1B(⬇) |
miR-140-3p(⬆) |
1 |
1 |
0 |
1 |
1 |
1 |
|
DDX3Y(⬆) |
miR-451(⬇) |
1 |
1 |
0 |
1 |
0 |
1 |
|
OXTR(⬇) |
miR-451(⬇) |
1 |
1 |
0 |
1 |
1 |
1 |
|
SETD5(⬆) |
miR-451(⬇) |
1 |
1 |
0 |
1 |
1 |
1 |
|
EIF1AY(⬆) |
miR-30e(⬆) |
1 |
1 |
1 |
1 |
1 |
1 |
|
IL1A(⬇) |
miR-30e(⬆) |
1 |
1 |
1 |
1 |
1 |
1 |
|
ZFY(⬆) |
miR-30e(⬆) |
1 |
1 |
1 |
1 |
1 |
1 |
|
EGR3(⬇) |
miR-142-5p(⬆) |
1 |
1 |
0 |
1 |
1 |
1 |
|
EIF1AY(⬆) |
miR-142-5p(⬆) |
1 |
1 |
0 |
1 |
1 |
1 |
|
GYPA(⬇) |
miR-142-5p(⬆) |
1 |
1 |
0 |
1 |
1 |
1 |
|
OR51E2(⬇) |
miR-142-5p(⬆) |
1 |
1 |
0 |
1 |
1 |
1 |
|
MMP8(⬇) |
miR-199a-3p(⬇) |
0 |
1 |
0 |
1 |
0 |
0 |
|
SEZ6L2(⬇) |
miR-199a-3p(⬇) |
0 |
0 |
0 |
1 |
0 |
1 |
|
B4GALNT3(⬆) |
miR-199a-3p(⬇) |
1 |
1 |
0 |
1 |
1 |
0 |
|
EIF1AY(⬆) |
miR-199a-3p(⬇) |
1 |
1 |
0 |
1 |
1 |
0 |
|
OXTR(⬇) |
miR-378(⬆) |
1 |
1 |
0 |
1 |
1 |
1 |
|
MLYCD(⬆) |
miR-595(⬇) |
1 |
1 |
0 |
1 |
1 |
0 |
|
OXTR(⬇) |
miR-595(⬇) |
1 |
1 |
0 |
1 |
1 |
1 |
|
IL1A(⬇) |
miR-181a(⬆) |
1 |
1 |
1 |
1 |
1 |
1 |
|
OR51E2(⬇) |
miR-181a(⬆) |
1 |
1 |
0 |
1 |
1 |
1 |
|
SLC6A8(⬇) |
miR-1268(⬇) |
0 |
1 |
0 |
1 |
1 |
1 |
|
B4GALNT3(⬆) |
miR-1268(⬇) |
0 |
1 |
0 |
1 |
1 |
1 |
|
GYPA(⬇) |
miR-181d(⬇) |
1 |
1 |
1 |
1 |
1 |
1 |
|
IL1A(⬇) |
miR-181d(⬇) |
1 |
1 |
1 |
1 |
1 |
1 |
|
HTRA3(⬇) |
miR-101(⬆) |
1 |
1 |
1 |
1 |
1 |
1 |
|
C8orf4(⬇) |
miR-101(⬆) |
1 |
1 |
1 |
1 |
1 |
1 |
|
NR4A1(⬇) |
miR-486-5p(⬇) |
1 |
0 |
0 |
1 |
1 |
1 |
|
EREG(⬇) |
miR-142-3p(⬆) |
1 |
1 |
0 |
1 |
1 |
1 |
|
LALBA(⬇) |
miR-142-3p(⬆) |
1 |
1 |
0 |
1 |
1 |
1 |
|
OR51E2(⬇) |
miR-142-3p(⬆) |
1 |
1 |
0 |
1 |
1 |
1 |
|
CTTN(⬇) |
miR-142-3p(⬆) |
1 |
1 |
0 |
1 |
1 |
1 |
|
LALBA(⬇) |
miR-324-5p(⬆) |
1 |
1 |
0 |
1 |
1 |
1 |
| ZFY(⬆) | miR-144(⬆) | 1 | 1 | 0 | 1 | 1 | 1 |
*T2D – type 2 diabetes and GDM – gestational diabetes.
#Algorithms for mRNA/miRNA interactions.
Number 1 represents predicted interaction and number 0 indicates non-predicted interaction.
⬆ mRNA or miRNA upregulation and ⬇mRNA or miRNA downregulation.